Blood. 2020 Dec 10;136(24):2838. doi: 10.1182/blood.2020009047.
PMID:33301038
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM, Tefferi A.
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
PMID:36601682
Standardizing dysgranulopoiesis in MDS and AML: refining diagnostics and laying the foundation for novel morphological-genetic correlations.
Rauh MJ.
Leuk Res. 2014 Apr;38(4):428-9. doi: 10.1016/j.leukres.2014.01.003. Epub 2014 Jan 11.
PMID:24472687
Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemia.
Xu Y, Dolan MM, Nguyen PL.
Am J Clin Pathol. 2003 Nov;120(5):778-84. doi: 10.1309/P2QU-GBB9-NVWV-4JUD.
PMID:14608906
Images from the Haematologica Atlas of Hematologic Cytology: dysgranulopoiesis.
Invernizzi R.
Haematologica. 2021 May 1;106(5):1229. doi: 10.3324/haematol.2021.278517.
PMID:33938210
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.